Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1801 to 1825 of about 5880

Previous 25

Website Changes

08/26/2015

WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials

08/26/2015

Enrollment Begins In Expansion Phase of ONC201 Clinical Trial

08/26/2015

Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.

08/25/2015

FDA Grants Orphan Drug Designation for Tocagen`s Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma

08/24/2015

?Celldex and the limits of ‘overall survival benefit’ in cancer trials

08/24/2015

Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement

08/24/2015

NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing Patients In Trial Continuing To Be Treated Per Protocol, Including In Germany

08/24/2015

Update posted for Ben Williams` "Treatment Options for Glioblastoma and other Gliomas"

08/17/2015

San Diego couple trying to stop time with Novocure

08/17/2015

Added survivor story Debbie - 10 year GBM survivor!

08/14/2015

Cleveland Clinic researcher awarded National Cancer Institute`s Outstanding Investigator Award

08/14/2015

ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma

08/12/2015

Can a Lung Cancer Drug Fight Brain Tumors?

08/09/2015

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

08/05/2015

Colchicine derivative as a potential anti-glioma compound.

08/05/2015

Musella Foundation Copayment Assistance Program is now closed to new patients

08/05/2015

07/27/2015

Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use

07/27/2015

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.

07/18/2015

Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis.

07/18/2015

ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.

07/18/2015

The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature.

07/18/2015

Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.

07/13/2015

Ottawa Hospital launches world`s first clinical trial of double-virus cancer treatment

07/13/2015

FDA Grants Fast Track Designation to Tocagen’s Toca 511 & Toca FC for Treatment of Recurrent High Grade Glioma

Our privacy / cookie policy has changed.
Click HERE to read it!